We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Vircell S.L.

Vircell is a biotechnology company specialized in the development and production of ready-to-use reagents for the dia... read more Featured Products: More products

Download Mobile App





Vircell Exhibits Its New VirClia Lotus and qSPEED-OLIGO Systems at MEDLAB

By LabMedica International staff writers
Posted on 05 Feb 2020
Print article
Illustration
Illustration
Vircell (Granada, Spain) exhibited its new instruments, VirClia Lotus and qSPEED-OLIGO, at MEDLAB Middle East, an event for showcasing the latest technology and knowledge in the IVD and medical laboratory market that was held at the Dubai International Convention and Exhibition Centre from February 3-6, 2020.

Vircell is a microbial biotechnology company which develops, manufactures and markets ready-to-use kits for the diagnosis of esoteric infectious diseases. It is specialized in the development and production of ready-to-use reagents for the diagnosis of infectious diseases in humans by different techniques – ranging from the traditional cell culture to the most innovating developments in the field of molecular biology.

At this year’s MEDLAB Middle East, Vircell exhibited VirClia Lotus, its new Chemiluminescence system (CLIA) designed to process diagnostic immunoassays VirClia Monotest. The VirClia Lotus CLIA system offers random access with continuous loading, STAT function to manage urgent samples, and positive identification of samples and strips through an internal scanner. It delivers the firsts results in one hour (new result every 30 seconds), 40 tests in one hour 25 minutes, and 80 tests in two hours 30 minutes with a capacity of 50 primary tubes and/or aliquots.

Vircell also presented its new approach on molecular biology, the qSPEED-OLIGO which is a unique molecular diagnostic tool for real-time PCR multiplex testing of infectious diseases and offers automated identification of positive samples. The qSPEED-OLIGO system includes a two-channel fluorescence thermocycler which allows for the screening of all pathogens (FAM) and for the internal control and sample validation (HEX). It helps rapidly discard negatives and focus only on identifying positive samples. The benchtop modular instrument increases laboratory throughput with automated screening of 48 samples in less than 90 minutes. It provides the advantage of minimum hands-on-time protocol by using pre-dispensed qPCR tubes and sealed cassettes to rule out contamination.

Related Links:
Vircell

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.